02.10.26 -- Putting Pressure On CDMOs With Herman Bozenhardt

Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

Review the results obtained for our proprietary HEK293T 2G7 suspension cell line for LVV production by transient transfection in serum-free, chemically-defined and animal component-free media.

From minimizing costs and accessing advanced tech to speeding market entry, dive into how outsourcing drug development and manufacturing to CMOs/CDMOs offers strategic advantages.

As developers begin their AAV therapy research, opting to conduct early phase studies with an experienced CDMO can help mitigate funding challenges and procure material for clinical data.

Early planning for scale-up and biologics license application activities can maximize your chances of success by allowing sufficient time to develop launch options and prevent costly delays and setbacks.

Learn more about the cutting-edge technologies driving the shift to microbial expression and how the right outsourcing partner can help you leverage the benefits of these innovative therapeutics.

Fast‑Track Pharmaceutical Analytical Services quickly identify and resolve manufacturing failures, reducing delays, controlling costs, and safeguarding patient safety through rapid forensic analysis.

Partner with a CDMO that understands the unique challenges of emerging biopharma, providing expert guidance in formulation development, manufacturing, and regulatory navigation.

Automated visual inspection (AVI) combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines.

Accelerate the development of next-generation cancer therapies with optimized ADC solutions designed to meet the diverse needs of global clients.